These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18937625)

  • 21. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
    Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ; Holst JJ; Schmidt WE; Nauck MA
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice.
    O'Harte FP; Hunter K; Gault VA; Irwin N; Green BD; Greer B; Harriott P; Bailey CJ; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1674-82. PubMed ID: 17299087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying.
    Asakawa A; Ueno N; Katagi M; Ijuin Y; Morita Y; Mizuno S; Inui T; Sakamaki R; Shinfuku N; Uemoto M
    J Diabetes Complications; 2006; 20(1):56-8. PubMed ID: 16389169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes.
    Gault VA; Flatt PR; Bailey CJ; Harriott P; Greer B; Mooney MH; O'harte FP
    Biochem J; 2002 Nov; 367(Pt 3):913-20. PubMed ID: 12150711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
    Irwin N; Hunter K; Flatt PR
    Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
    Gault VA; Irwin N; Green BD; McCluskey JT; Greer B; Bailey CJ; Harriott P; O'harte FP; Flatt PR
    Diabetes; 2005 Aug; 54(8):2436-46. PubMed ID: 16046312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active immunization with glucose-dependent insulinotropic polypeptide vaccine influences brain function and behaviour in rats.
    Tian JQ; Wang Y; Lin N; Guo YJ; Sun SH; Zou DJ
    Scand J Immunol; 2010 Jul; 72(1):1-7. PubMed ID: 20591069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A
    Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice.
    Dong F; Yang X; Sreejayan N; Ren J
    Obesity (Silver Spring); 2007 Nov; 15(11):2699-711. PubMed ID: 18070761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes.
    Yamada C; Yamada Y; Tsukiyama K; Yamada K; Yamane S; Harada N; Miyawaki K; Seino Y; Inagaki N
    Biochem Biophys Res Commun; 2007 Dec; 364(1):175-80. PubMed ID: 17937928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the gut Peptide glucose-induced insulinomimetic Peptide in energy balance.
    Pfeiffer AF; Rudovich N; Weickert MO; Isken F
    Results Probl Cell Differ; 2010; 52():183-8. PubMed ID: 20865381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
    Porter WD; Flatt PR; Hölscher C; Gault VA
    Int J Obes (Lond); 2013 May; 37(5):678-84. PubMed ID: 22665137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice.
    Boylan MO; Glazebrook PA; Tatalovic M; Wolfe MM
    Am J Physiol Endocrinol Metab; 2015 Dec; 309(12):E1008-18. PubMed ID: 26487006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
    Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
    Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
    Cassidy RS; Irwin N; Flatt PR
    Biol Chem; 2008 Feb; 389(2):189-93. PubMed ID: 18163884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
    Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
    Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.